TY - JOUR
T1 - Radiotherapy in cutaneous lymphomas
T2 - Recommendations from the EORTC cutaneous lymphoma tumour group
AU - Elsayad, Khaled
AU - Guenova, Emmanuella
AU - Assaf, Chalid
AU - Nicolay, Jan P
AU - Trautinger, Franz
AU - Stadler, Rudolf
AU - Waldstein, Cora
AU - Boterberg, Tom
AU - Meijnders, Paul
AU - Kirova, Youlia
AU - Dobos, Gabor
AU - Duque-Santana, Victor
AU - Riggenbach, Elena
AU - Elsheshtawy, Wael
AU - Niezink, Anne
AU - Papadavid, Evangelia
AU - Scarisbrick, Julia
AU - Vermeer, Maarten
AU - Neelis, Karen J
AU - Bagot, Martine
AU - Battistella, Maxime
AU - Quaglino, Pietro
AU - Knobler, Robert
AU - Kempf, Werner
AU - Maklad, Ahmed
AU - Adeberg, Sebastian
AU - Kouloulias, Vassilis
AU - Simontacchi, Gabriele
AU - Corradini, Stefanie
AU - König, Laila
AU - Eich, Hans Theodor
AU - Cowan, Richard
AU - Correia, Dora
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/11
Y1 - 2024/11
N2 - The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.
AB - The number of primary cutaneous lymphoma patients receiving low-dose radiotherapy is increasing, though controlled clinical trials defining the standard radiation dose for each specific entity have not yet been completed. Radiation oncologists are left with making highly individualized decisions that would be better enriched by additional clinical evidence. In this expert opinion, we aim to provide a clear recommendation to improve the current practice of radiation oncology. In addition, existing literature has been reviewed to develop recommendations for all types of primary cutaneous lymphoma. A prospective trial is urgently needed to identify the factors influencing patient outcomes following different radiation doses.
KW - Humans
KW - Lymphoma, T-Cell, Cutaneous/radiotherapy
KW - Mycosis Fungoides/radiotherapy
KW - Practice Guidelines as Topic
KW - Radiotherapy Dosage
KW - Skin Neoplasms/radiotherapy
KW - Radiation Oncology/standards
UR - http://www.scopus.com/inward/record.url?scp=85206255636&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2024.115064
DO - 10.1016/j.ejca.2024.115064
M3 - Review article
C2 - 39418694
SN - 0959-8049
VL - 212
SP - 115064
JO - European Journal of Cancer
JF - European Journal of Cancer
M1 - 115064
ER -